tiprankstipranks
Trending News
More News >

Aoxin Q&M Dental Group Faces Financial Impact from Excess Claim Refund

Story Highlights
Aoxin Q&M Dental Group Faces Financial Impact from Excess Claim Refund

Don’t Miss TipRanks’ Half-Year Sale

An update from Aoxin Q&M Dental Group Ltd. ( (SG:1D4) ) is now available.

Aoxin Q&M Dental Group Ltd. announced that its two hospitals in China have identified an excess claim of approximately RMB3.7 million in material costs under the government medical co-payment scheme for FY2024, following a self-review mandated by the National Healthcare Security Administration. This refund is expected to materially impact the company’s financials in the first half of FY2025, and shareholders are advised to trade cautiously.

More about Aoxin Q&M Dental Group Ltd.

Aoxin Q&M Dental Group Ltd., incorporated in Singapore, operates in the healthcare industry, focusing on dental services. The company manages hospitals and clinics, providing dental treatments and related services, with a market focus on leveraging government medical co-payment schemes in China.

Average Trading Volume: 111,009

Technical Sentiment Signal: Sell

Current Market Cap: S$22.51M

For a thorough assessment of 1D4 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1